A recent study has reported that matrine and scopoletin are effective ingredients of the Qinghao–Kushen combination combating liver cancer, which reduce the expression of GSK-3β in HepG2 cells and upregulate GSK-3β in HepG2.2.15 cells (Ji et al., 2022). The gene discussed is GSK3B; the disease is liver cancer.